RxSight, Inc. (RXST)
NASDAQ: RXST · IEX Real-Time Price · USD
16.40
-0.27 (-1.62%)
Mar 27, 2023, 4:00 PM EDT - Market closed
Cash Flow Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|
Net Income | -66.76 | -48.69 | 3.37 | 26.13 |
Depreciation & Amortization | 4.02 | 3.99 | 4.01 | 3.93 |
Share-Based Compensation | 11.4 | 7.58 | 4.19 | 4.6 |
Other Operating Activities | -7.51 | -7.58 | -70.98 | -175.37 |
Operating Cash Flow | -58.85 | -44.71 | -35.2 | -40.62 |
Capital Expenditures | -2.39 | -1.94 | -2.54 | -3.48 |
Change in Investments | 42.34 | -79.97 | 18.13 | -2.39 |
Investing Cash Flow | 39.95 | -81.91 | 15.59 | -5.87 |
Share Issuance / Repurchase | 7.83 | 121.14 | 0.99 | 1.52 |
Debt Issued / Paid | -0.27 | 14.84 | 24.17 | -0.19 |
Other Financing Activities | -1.23 | 1.37 | 0.07 | - |
Financing Cash Flow | 6.33 | 137.34 | 25.24 | 1.33 |
Net Cash Flow | -12.58 | 10.72 | 5.63 | -45.15 |
Free Cash Flow | -61.24 | -46.65 | -37.74 | -44.1 |
Free Cash Flow Margin | -124.97% | -206.47% | -257.11% | -1967.96% |
Free Cash Flow Per Share | -2.21 | -3.42 | -10.18 | - |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).